As per a recently published study by Future Market Insights, the global Andersen Tawil syndrome treatment market is expected to surpass an impressive valuation of US$ 1.9 Billion in 2023 and is projected to reach US$ 4.2 Billion by 2033, with a CAGR of 8.26%. Rising government assistance, provision of incentives to.
Today, November 17, 2022, MedCap AB (publ) disclosed a public takeover offer to
the shareholders of Karo Pharma Aktiebolag. The rules of Nasdaq First North Growth Market state that an issuer may be given
observation
/PRNewswire/ The Board of Directors of Karo Pharma Aktiebolag ("Karo Pharma" or the "Company") has resolved to apply for de-listing of the Company s shares.
On August 16, 2022, the shares in Karo Pharma Aktiebolag (the "Company") were
given observation status with reference to a public takeover offer from Karo
Intressenter AB to the other shareholders in the
/PRNewswire/ Karo Intressenter AB[1] ("Karo Intressenter") announced a public cash offer to the shareholders in Karo Pharma Aktiebolag ("Karo Pharma" or the.